$599

Basal Insulin, Bolus Insulin, GLP-1RA, Glucagon, Glucose Monitoring, Insulin Delivery, Other, Topics

February 18, 2026

Beta Bionics and Insulet Q4 ’25 Earnings; Lilly Taltz+Zepbound PsO Combination Data; Zealand Ph1a Kv1.3 Inhibitor Topline Results

A series of cardiometabolic-related news items has been observed from Beta Bionics, Insulet, Lilly, and Zealand Pharma. Below, FENIX provides highlights and insights on the respective news items.

This content is for Read Less members only.
Register

Already a member? Log in here

Return to Home